The effect of iron and omega-3 on coronary heart disease
- Conditions
- Condition 1: Iron deficiency anaemia. Condition 2: Iron deficiency anaemia.Iron deficiency anaemia, unspecifiedOther iron deficiency anaemias
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 80
• Serum ferritin less than 12 ? g / l and serum iron of 60 mcg/100ml • Women in the range of 15 to 45 years of age • regular menstrual cycles • willingness to cooperate and fill the criteria of informed consent form to the project exclusion criteria: • smoking tobacco or alcohol • iron supplements, multivitamins and antioxidants in the last three months • the use of lipid-lowering drugs, oral contraceptives • the use of oral contraceptives • parasitic infections (those who have been diagnosed positive stool test will be excluded.) • thalassemia disease • kidney disease, liver disease, diabetes • local or systemic infection or inflammatory disease • history of ulcer disease or gastrointestinal bleeding or fibroids •malabsorption such as celiac sprue or steatorrhea • Any type of blood transfusion in the last 2 months of • pregnancy or lactation • not wanting to continue working • inadequate compliance supplement (compliance less than 80%) • change in diet or physical activity for any reason
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting serum ferritin. Timepoint: before the experiment.12 weeks after intervention. Method of measurement: According ? g / l Lyazvn method.;Paraoxonase 1 activity. Timepoint: before the experiment.12 weeks after intervention. Method of measurement: By U / L spectrophotometry.;Fasting serum ApoB levels. Timepoint: before the experiment.12 weeks after intervention. Method of measurement: Based on Mg / dl Turbydymtry method.;Fasting serum concentrations of ApoA1. Timepoint: before the experiment.12 weeks after intervention. Method of measurement: Based on Mg / dl Turbydymtry method.;Fasting concentrations of serum HS-CRP. Timepoint: before the experiment.12 weeks after intervention. Method of measurement: Based on Mg / l immunohistochemical method Flumtryk.;Fasting serum iron. Timepoint: before the experiment.12 weeks after intervention. Method of measurement: According ? g / dl spectrophotometry.
- Secondary Outcome Measures
Name Time Method